WHO WE ARE
AIVITA Biomedical is an immuno-oncology company designing personalized vaccines that target the seed of all cancers: tumor-initiating cells. We take a unique pan-antigenic approach—targeting all neoantigens, rather than a select few — allowing our treatments to overcome cancer’s tendency to mutate over time. Our unique expertise in stem cell growth and directed, high-purity differentiation enables us to develop safe, efficient and economical manufacturing processes for therapeutic development.
Our patient-specific treatments have shown tremendous promise in eradicating tumors without harmful side effects in our melanoma, glioblastoma and ovarian cancer clinical studies. We have also leveraged our approach to create a proprietary skincare line, which dedicates 100 percent of net proceeds towards advancing revolutionary treatments for patients with cancer. We explore additional applications in human health, including vision loss.